Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,473.47
(
0.37%
)
US TECH 100
28,612.40
(
0.11%
)
Dow Jones
50,579.70
(
0.58%
)
Brent Oil
101.17
(
0.00%
)
Bitcoin
76,723.10
(
1.61%
)
News Focus
News Focus
Post# of 257623
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 123010
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: genisi post# 72376

Thursday, 01/29/2009 6:11:06 PM

Thursday, January 29, 2009 6:11:06 PM

Post# of 257623

AstraZeneca is doubling the size of its cost-cutting plan-which means another 7,400 or so jobs face the ax by 2013.

What’s notable about this is that the cuts are not limited to sales and marketing; rather, some of them will be in R&D (see next post), as is the case with PFE’s recently announced cutback.


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today